Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
12,229 total articles
We upgrade Emergent BioSolutions (EBS) to Buy on attractive valuation, FCF generation and recent product & strategic wins. Technical oversold conditions and elevated short interest suggest continued volatility; we prefer to pick a precise entry at $7.50 while targeting $12.00 over a 180 trading-day horizon and using a $6.75 stop.
Nvidia remains the dominant supplier for AI compute. Market chatter around a customer called 'Nebius' suggests a new infrastructure deployment that could tilt near-term demand expectations—if real. Balance strong fundamentals - $4.45T market cap, $96.7B free cash flow, ROE 76% - against a premium multiple and mixed technical momentum. Trade idea: e…
GlobalFoundries priced a 20 million-share secondary at $42 by Mubadala with a concurrent $300 million buyback by the company. The deal reduces a headline dilution risk while expanding tradable float. Fundamentals remain intact: market cap ~$23.1B, PE ~26, and a deepening auto/industrial customer base. Technicals show the stock a touch weak below ke…
Zoetis (ZTS) is a dominant animal-health company trading at $114.81, near its 52-week low of $114.61. The business generates strong free cash flow ($2.283B) and earns high returns on equity (80%+), while valuation has compressed to roughly 18x trailing EPS. Technicals show oversold conditions and growing short interest. This trade idea outlines a m…
Triple Flag Precious Metals (TFPM) looks attractively priced for exposure to rising gold: market cap near $7.4B, a 52-week low of $17.72 but recent strength to $41.70 shows volatility and optionality. Current weakness offers a mid-term entry with defined risk and upside to the prior highs if gold continues its rally.
Sensible Meats (SSMTF) is an OTC-listed, early-stage cultured-meat company. FY25 margin erosion has pressured the story, but the core thesis - improving unit economics as production scales and regulatory progress unlocks commercialization - remains viable for patient, size-constrained speculators. This is a high-risk, asymmetric trade: small positi…
Boeing shares are trading near $207 after headlines about a new 737 MAX problem. The company still shows strong delivery performance, but an elevated valuation (P/E ~82-85, P/B ~29.5) combined with negative free cash flow and a high debt-to-equity ratio makes the stock vulnerable to an earnings or delivery disappointment. This trade idea outlines a…
Amazon looks set for a valuation re-rate as AWS benefits from AI infrastructure spending and retail efficiencies gradually improve. This trade idea outlines an actionable long with a clear entry, stop and target across a 45-trading-day horizon.
Tower Semiconductor's foundry push into silicon photonics is moving from R&D to pre-production and early commercialization. With partnerships and product announcements in February and institutional buying into capacity expansion, the stock looks ripe for a tactical long to capture initial revenue upside and re-rating. This trade targets the market'…
ATI (ATI) makes the special metals that modern aircraft and defense platforms need. With aerospace production recovering, high-value alloy demand rising, and limited global capacity for nickel/titanium products, ATI looks well positioned. We lay out a position-sized, risk-defined trade for a long entry at $144, stop at $128 and target of $165 over …
Nvidia is priced for growth but still has room to run into GTC 2026 if management delivers credible roadmaps for agentic AI and a new LPU product family. The trade is a mid-term tactical long with clear entry, stop and target, sized for disciplined risk-taking around the conference catalyst.
Enphase has been punished for inventory and guidance noise, but the business fundamentals - positive free cash flow, a $6.3B enterprise value, and improving technical posture - argue for a tactical long. This trade plan targets a measured rally toward prior highs while protecting capital against headline risk and litigation noise.
SoundHound AI sells core voice, sound and conversational AI to automotive, restaurant and enterprise customers. Revenue nearly doubled to $169M in 2025 and management guided $225M-$260M for 2026, but the stock has plunged from its 2025 highs and sits at a rich multiple that looks punchable on a trade. This idea lays out an actionable long trade: en…
Nvidia's fundamentals remain rock-solid: massive market cap, exceptional free cash flow and a high ROE. With technicals neutral and short interest elevated, an upcoming 'Nebius' catalyst could trigger a rapid repricing. This trade targets a mid-term move over the next 45 trading days with defined risk controls.
CI&T is showing signs of durable revenue growth driven by its AI-enabled Flow platform and an expanding North American footprint. At a market cap of roughly $722M and a forward-leaning strategy, the risk/reward for a long trade looks attractive if you respect a disciplined stop and the company continues to convert pipeline into bookings.
Atlassian still posts meaningful cash generation and keeps growing its enterprise footprint, but GAAP profitability has lagged. The stock trades at roughly 15x free cash flow and under $20B market cap — attractive for a company with durable products if management can convert revenue growth into margin expansion. This trade targets a rebound as AI t…
Brazil Potash (GRO) looks attractively priced for a long-term construction / pre-production re-rate. Market cap $182M, secured offtake for ~91% of planned volumes and a 10-year take-or-pay for ~900k tpa position the Autazes project as a meaningful domestic supply alternative. Trade plan: enter at $3.42, stop $2.70, target $6.00 on confirmation of 2…
Microsoft (MSFT) is a core long with resilient fundamentals and strong free cash flow. Use a mid-term (45 trading days) swing trade: entry $402.90, target $460.00, stop $372.00. Valuation looks reasonable for a market-cap leader: P/E ~25, EV/EBITDA ~17, free cash flow $77.4B, ROE 30.5% and low leverage. Catalysts include AI infrastructure spending …
Sandisk ($633.50) has been volatile after a breakout year but the fundamental drivers that pushed the stock higher - hyperscaler AI spending, tight NAND supply and improving data-center contracts - remain intact. The company has positive free cash flow, limited net debt and a still-deep float; that combination supports a tactical buy with a mid-ter…
Sutro Biopharma (STRO) is trading near its 52-week high after a financing and early-stage ADC progress. The trade idea is a cautious long: entry $24.50, target $32.00, stop $18.00, horizon 180 trading days. The thesis rests on momentum into multiple ADC programs and cleaner balance-sheet runway; the counterpoint is steep clinical and cash-flow risk…
Broadcom is winning AI infrastructure design wins and reported strong top-line and margin expansion, yet its valuation and exposure to hyperscaler capex cycles create a clear trade-off. We lay out a mid-term trade: buy on weakness near $339, target $380, stop $312, and explain the catalysts and risks that could make or break the trade over the next…
Oracle’s recent results show explosive AI infrastructure growth inside a cash flow-challenged capital structure. With cloud infrastructure up 84% and AI infrastructure revenue up 243% in the latest quarter, the company looks positioned to capture outsized demand for data-center capacity. This trade targets a measured long position that leans on con…
Microsoft is trading below key moving averages after a broad market risk-off. Fundamentals remain strong: $2.98T market cap, $77.4B free cash flow, 30% return on equity and a conservative balance sheet. This trade targets a recovery driven by AI infrastructure spending, steady cloud growth and buyback support. Entry $400.00, target $460.00, stop $3…
Stereotaxis builds robotic magnetic navigation systems for cardiac procedures. At a $175M market cap and an enterprise value near $165M, the stock offers asymmetric upside into an expanding magnetic ablation and medical robotics market, but negative EPS, recurring free-cash-flow deficits and tight liquidity make this a high-risk, high-reward swing …
Zoom Communications plunged after a softer-than-expected quarter and a cautious 2027 outlook. The pullback creates a risk-adjusted entry: the company sits on $7.8B of cash and generates roughly $1.8B in annual free cash flow, trading near 13x adjusted earnings. This trade idea targets a recovery/re-rating over the next 180 trading days while protec…
